(R)-alpha-(((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)benzeneacetic Acid, >95% (HPLC)

cas: 63422-71-9 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

(R)-alpha-(((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)benzeneacetic Acid, >95% (HPLC) (CAS 63422-71-9) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 1g. Oferty producentów: TRC.

• 2D
• 3D

(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid (CAS 63422-71-9) to związek chemiczny o wzorze sumarycznym C15H17N3O5 i masie molowej 319.31 g/mol. Nazwa systematyczna IUPAC: (2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid. InChIKey: JQEHQELQPPKXRR-LLVKDONJSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C15H17N3O5
Masa molowa	319.31 g/mol
Nazwa IUPAC	(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid
InChIKey	JQEHQELQPPKXRR-LLVKDONJSA-N
SMILES	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (R)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetic acid, (R)-(((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylaceticacid, (R)-(((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetic acid, PIPERACILLIN SODIUM IMPURITY G [EP IMPURITY], (R)-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]phenylacetic acid, PIPERACILLIN SODIUM IMPURITY G (EP IMPURITY), (2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid, Piperacillin Sodium EP Impurity G, (R)-alpha-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]benzeneacetic Acid, (R)-(-)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetic Acid

Powiązane formy tego związku

(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetic acid C₁₅H₁₇N₃O₅

Izomery (ten sam wzór sumaryczny)

3-ethoxy-4-[2-(2-methyl-5-nitroimidazol-1-yl)ethoxy]benzaldehyde C₁₅H₁₇N₃O₅

(Z)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide C₁₅H₁₇N₃O₅

(Z)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide C₁₅H₁₇N₃O₅

N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]formamide C₁₅H₁₇N₃O₅

(E)-2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide C₁₅H₁₇N₃O₅

methyl 4-amino-1-[(2-methoxy-4-methoxycarbonylphenyl)methyl]pyrazole-5-carboxylate C₁₅H₁₇N₃O₅

ethyl 3,4-dimethyl-6-(4-nitrophenyl)-2-oxo-1,6-dihydropyrimidine-5-carboxylate C₁₅H₁₇N₃O₅

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid C₁₅H₁₇N₃O₅

(E)-4-[2-[4-(benzylamino)-4-oxobutanoyl]hydrazinyl]-4-oxobut-2-enoic acid C₁₅H₁₇N₃O₅

3-(2-aminoethyl)-1H-indole-5-carboxamide;(Z)-but-2-enedioic acid C₁₅H₁₇N₃O₅

(Z)-but-2-enedioic acid;(10R)-10-(methylamino)-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one C₁₅H₁₇N₃O₅